Business · 20/03/2024
FDA Proposes Criteria for Compounding Difficulty Lists
The FDA is proposing to establish criteria for listing drug products that pose challenges for compounding under certain sections of the Federal Food, Drug, and Cosmetic Act, and will identify the first three categories of such products.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →